Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sep 17, 2010

Premium

BAC this week launched its CaptureSelect HumanPlasma14 product for the specific, reproducible depletion of the 14 most abundant proteins in human blood plasma or serum.

The product, which uses single-domain monospecific antibodies immobilized on high-capacity agarose-based beads, is intended for preparing samples for downstream analysis by applications like gel electrophoresis and mass spectrometry. It enables the single-step, single-use depletion of more than 99 percent of the targeted protein, the company said.


Gentel Biosciences this week launched 13 APiX Human Tumor Profiling Kits – reverse-phase protein arrays and chromogenic-based detection reagents to be used for testing putative protein biomarkers in over 13 cancer subtypes.

The kits are configured for use with Gentel's Proteomics Multi-System and AthenaQuant analysis software. The company is offering scanning and data reporting for each new customer's initial kit purchase.


Phoenix S&T this week announced the US and UK availability of its liquid chromatography capillary column heaters and controllers.

Designed to provide more robust and reproducible LC results, the devices are particularly suited for micro-nano LC/MS applications in proteomics, the company said.


Waters this week introduced its new Ostro Sample Preparation Plate for the removal of phospholipids from biological samples, a main cause of matrix effects in LC/MS analysis.

Featuring a 96-well format, the Ostro plate removes up to 30 times more phospholipids than other removal devices and traditional liquid-liquid extraction methods, the company said.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.